SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drug informs about press release

16 Dec 2022 Evaluate
Godavari Drug has informed that it enclosed hard copies of Press release issued on 16.12.2022 in one English newspaper namely Business Standard and Bengali newspaper, Sangbad Pratidin publishing notice of Transfer of Unclaimed Interim Dividend 2015-16 and Equity Shares of Coal India (CIL) to IEPF Authority.

The above information is a part of company’s filings submitted to BSE.

Godavari Drugs Share Price

126.80 0.20 (0.16%)
07-May-2026 09:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.10
Dr. Reddys Lab 1304.50
Cipla 1371.25
Zydus Lifesciences 940.80
Lupin 2459.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×